Dr. Manoj Agarwal, MBA, MD

Dr. Agarwal practices at Plastic Surgery Clinic: Vincent Muoneke MD in Burien, Washington.

Dr. Agarwal's NPI, 1700891900, was assigned on July 29, 2006. Dr. Agarwal holds Washington license MD61246647.

Dr. Agarwal's primary practice is Plastic Surgery Clinic: Vincent Muoneke MD, at 16233 Sylvester SW Rd, Burien, WA 98166 in King County. The practice phone is (206) 248-6992.

Dr. Agarwal's primary practice is Plastic Surgery Clinic: Vincent Muoneke MD in Burien, Washington. Dr. Agarwal is also affiliated with St. Anne Hospital. The medical group on file is Franciscan Orthopedics - Silverdale. Dmand AI also links Dr. Agarwal to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Agarwal is licensed in Washington.

CMS data shows 635 Medicare services from Dr. Agarwal across 13 procedure codes in 2024, for 207 Medicare patients. Medicare paid $34,220 for them.

CMS counts 207 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 75 to 84, with 91 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 68, with 60% women.

In 2024, Dr. Agarwal wrote 559 Medicare Part D claims for 163 patients. 75% of them were for generic drugs. CMS names the drug for 406 of them, across 20 drugs with 11 or more claims each, at $780,713 in total drug cost. In 2023, CMS named 492 claims across 18 drugs.

Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agarwal as offering telehealth.

Dmand AI links 11 papers to Dr. Agarwal, published from 2014 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Catheter-Related Infections. Dr. Agarwal's most frequent co-authors are Yatin B. Mehta, MD, Nirav K. Pandya, MD and Philip Abraham, MD.

CMS Open Payments shows 69 general payments to Dr. Agarwal from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. AstraZeneca Pharmaceuticals LP paid the most, $10,991.